NCT02984293View on ClinicalTrials.gov

Statin Immune Study

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 17, 2017

Primary Completion Date

November 3, 2017

Study Completion Date

November 3, 2017

Conditions
Drug Intolerance
Interventions
DRUG

Atorvastatin

Atorvastatin 80 mg once daily for 28 days.

DRUG

Placebo

Placebo once daily for 28 days.

Trial Locations (1)

DD1 9SY

University of Dundee, Dundee

All Listed Sponsors
collaborator

NHS Tayside

OTHER_GOV

lead

University of Dundee

OTHER

NCT02984293 - Statin Immune Study | Biotech Hunter | Biotech Hunter